1994
DOI: 10.1016/s0021-9258(17)37146-6
|View full text |Cite
|
Sign up to set email alerts
|

A proteolytic fragment of Trypanosoma cruzi trans-sialidase lacking the carboxyl-terminal domain is active, monomeric, and generates antibodies that inhibit enzymatic activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
21
0

Year Published

1999
1999
2022
2022

Publication Types

Select...
6
1
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(22 citation statements)
references
References 30 publications
1
21
0
Order By: Relevance
“…Ligands. TS used in this study was a His-tagged 70 kDa recombinant protein truncated to remove C-terminal repeats but retaining the catalytic N-terminal domain of the enzyme 33 that contains several antigenic determinants located in solventexposed areas. 37 CrP was obtained essentially homogeneous, starting from crude T. cruzi epimastigote Y strain extracts, in one step, by affinity chromatography.…”
Section: ■ Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Ligands. TS used in this study was a His-tagged 70 kDa recombinant protein truncated to remove C-terminal repeats but retaining the catalytic N-terminal domain of the enzyme 33 that contains several antigenic determinants located in solventexposed areas. 37 CrP was obtained essentially homogeneous, starting from crude T. cruzi epimastigote Y strain extracts, in one step, by affinity chromatography.…”
Section: ■ Methodsmentioning
confidence: 99%
“…Although previous studies have reported that the catalytic domain of TS can be used for the diagnosis of chronic CD, 29 the fact that a TS-based SPR immunosensor cannot distinguish between sera from T. cruzi infected patients and control individuals (Figure 2B) can be related to the use of higher serum dilutions in comparison to ELISA, which hinders the possibility of detecting the specific low titer antibodies. 33,34 The possibility to enhance the detection of the specific anti-T. cruzi antibodies in Au-MPA-CrP and Au-MPA-TS sensor platforms by minimizing the impact of non-specific adsorption of serum proteins to the sensor surface still exists. In Figure 3, the relative Δθ SPR (Δθ POS /Δθ NEG ) corresponding to the interaction of positive and negative serum dilutions with Au-MPA-CrP and Au-MPA-TS after the blockage of the nonreactive sites with 1% BSA or 1 M ethanolamine is presented.…”
mentioning
confidence: 99%
“…The trans-sialidase used in this study was a His-tagged 70 kDa recombinant material truncated to remove C-terminal repeats but retaining the catalytic N-terminal domain of the enzyme. 22 The preparation of the compound libraries screened in this study § Elsewhere we have exploited these observations in the design of novel TcTS acceptor analogue inhibitors 11e and glycomacrocycle substrates 32 for TcTS based on triazole-linked 6-disubstituted b-galactosides.…”
Section: Methodsmentioning
confidence: 99%
“…Smith and Eichinger reported the expression and characterisation of Trypanosoma cruzi TS (TcruTS)/ Trypanosoma rangeli sialidase (TranSA) hybrid proteins, exhibiting different Sia transfer and sialidase activities [16]. They found that the C-terminal Fn3 domain (fibronectin type III), named according to its structural relation to fibronectin type III, is not only required for expression of enzymatically active TcruTS and TranSA [17][18][19], but also influences the overall Sia transfer and sialidase activities [16]. Amino acid sequence alignments of a well characterised sialidase from Macromonospora viridifaciens [20] with TcruTS revealed that R572 and E578, which are known to be essential for galactose binding of M. viridifaciens sialidase [20], are well conserved in TcruTS and TranSA [16].…”
Section: Introductionmentioning
confidence: 99%